Prognostic utility of serum YKL-40 in patients with cervical cancer

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

Berit Jul Mosgaard

doi:10.1080/00365513.2020.1846209

Prognostic utility of serum YKL-40 in patients with cervical cancer

Berit Jul Mosgaard · 2020-11-13

Inflammation is one of the hallmarks of cancer and plays a crucial role in the development and progression. The objective of the present study was to investigate if high serum YKL-40 is related to poor prognosis in cervical cancer (CC) patients. A prospective biomarker study of 116 patients with CC (FIGO stage Ia:

Prognostic utility of serum YKL-40 in patients with cervical cancer

Links

Journal

Institutions

Authors

Funding